التفاصيل البيبلوغرافية
العنوان: |
525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors |
المؤلفون: |
Symeonides, Stefan, Mahalingam, Devalingam, Chae, Young Kwang, Calvo, Emiliano, Miguel, Maria, Arkenau, Hendrik-Tobias, Garralda, Elena, Galvao, Vladimir, Mita, Alain, Hassan, Hariz, Baumhauer, Annette, Völker, Timo, Kühnle, Marie-Cristine, Rösemann, Roman, Strobl, Stefan, Tuereci, Oezlem, Sahin, Ugur |
المصدر: |
Regular and Young Investigator Award Abstracts |
بيانات النشر: |
BMJ Publishing Group Ltd |
سنة النشر: |
2021 |
نوع الوثيقة: |
conference object |
اللغة: |
unknown |
DOI: |
10.1136/jitc-2021-sitc2021.525 |
DOI: |
10.1136/jitc-2021-SITC2021.525 |
الإتاحة: |
https://doi.org/10.1136/jitc-2021-sitc2021.525Test |
رقم الانضمام: |
edsbas.555A14EE |
قاعدة البيانات: |
BASE |